Predictive Factors for a Successful Return to Run After ACL-R
Predictive Factors for a Successful Return to Run After Anterior Cruciate Ligament Reconstruction and Underlying Bio-mechanical Factors
After anterior cruciate ligament (LCA) rupture, the recommended treatment for athletes is the surgical reconstruction of the ligament (ACL-R), followed by a long rehabilitation period. The results of this treatment are sub-optimal with a low rate of return to pre-injury level of sport, a high risk of reinjury and early knee osteoarthritis. To improve treatment outcomes, researchers and clinicians recommend optimizing rehabilitation protocols. They recommend individualizing rehabilitation progression based on objective criteria. However, current defined criteria relied on experts' opinions and not scientific validation.
Return to run after ACL reconstruction is an important rehabilitation milestone. It often means the beginning of the return to sport continuum. A successful return to run is therefore crucial for both the patient and clinician. In this study, the investigators aim to determine the predictive outcomes for a successful return to run after ACL-R.
研究概览
研究类型
注册 (实际的)
阶段
- 不适用
联系人和位置
学习地点
-
-
Quebec
-
Quebec City、Quebec、加拿大
- Center for Interdisciplinary Research in Rehabilitation and Social Integration (CIRRIS)
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Experimental group
Inclusion Criteria:
- ACL-R 3 to 4 months ago
Exclusion Criteria:
- already returned to run
- multiple ligament lesions
Control group
Inclusion Criteria:
- healthy person
Exclusion Criteria:
- history of ACL lesion or reconstruction
- history of knee injury
- injured in the last year
学习计划
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:非随机化
- 介入模型:并行分配
- 屏蔽:无(打开标签)
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
无干预:控制
|
|
|
实验性的:ACL-R
|
Progressive return to run protocol for patients after ACL-R
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Muscular strength assessment
大体时间:Day 0
|
Quadriceps, hamstring and gluteus strength assessment with handheld dynamometer (N)
|
Day 0
|
|
Modified Y-balance test
大体时间:Day 0
|
Modified Y-balance test (m)
|
Day 0
|
|
step-down test
大体时间:Day 0
|
endurance test, number of repetition
|
Day 0
|
|
Self-reported outcomes: ACL-RSI
大体时间:Day 0
|
ACL-RSI: 0-100
|
Day 0
|
|
Self-reported outcomes: IKDC
大体时间:Day 0
|
IKDC: 0-100
|
Day 0
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Running kinematic
大体时间:Day 0 and Day 14
|
knee kinematic (degree)
|
Day 0 and Day 14
|
|
Running kinetic
大体时间:Day 0 and Day 14
|
kinetic (N)
|
Day 0 and Day 14
|
|
Knee joint contact force
大体时间:Day 0 and Day 14
|
knee joint contact force (N)
|
Day 0 and Day 14
|
合作者和调查者
调查人员
- 首席研究员:Jean-Sébastien Roy, PhD、Laval University
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (实际的)
研究完成 (实际的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他研究编号
- ACLR/Running 2019
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.